中原內配(002448.SZ)與通用汽車公司簽署重要供貨合同 合同總金額約1億美元
格隆匯5月15日丨中原內配(002448.SZ)公佈,公司於近日與General Motors LLC(通用汽車有限公司)(以下簡稱"通用汽車公司")簽署了《購貨合同》,合同期限內總金額約1億美元。
依據新產品驗證流程及通用汽車公司產量需求預測,本合同項下產品預計自2024年四季度實現批量供貨。因此,本次合同的實施對公司本年度經營業績無重大影響,預計將對公司未來的經營業績產生一定積極作用。
據悉,通用汽車公司位於美國密歇根州底特律,位於作為全球最大的汽車公司之一,主要從事卡車、跨界車、轎車和汽車零部件的設計、製造和銷售等。通用汽車公司經營狀況良好,具有較好的信譽和履約能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.